Many of us believe that our emotions are fixed entities that are hardwired into our brains or automatically triggered by situations that provoke them. Rejection makes us feel bad; success makes us feel good. Or some people are just angry people, while others are happy souls. We also might believe that emotions can be controlled by just changing our thinking. Neuroscientists say otherwise. Northeastern University neuroscientist Lisa Feldman Barrett has done extensive research into how emotions work in the brain and has come to the conclusion that emotions and thoughts are not separate processes; instead, the entire brain actively constructs both thoughts and emotions by billions of neurons signaling each other. Our brains are plastic and can change with new concepts.
Neuroscience is a study of that is concerned with the structure and function of the nervous system. The study covers the evolution, development, physiology, cellular & molecular biology, anatomy & pharmacology of the nervous system, and also behavioral, computational and cognitive neuroscience. Tools such as MRI scans and computerized 3-D models are used to perform tests for some common conditions including Down syndrome, Parkinson’s disease, brain tumors, effects of stroke such as, language loss and many others.
Download Full PDF@ http://bit.ly/2S47hj3
North America is expected to contribute to the largest share in the neuroscience market in the coming years, due to rising focus on the development of new products and the rising awareness regarding to the benefits of advanced neuroscience devices in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to growing government spending on the healthcare infrastructure and rising spending on the research and development activities in the region.
Some of the key players operating in the neuroscience market include:- General Electric Company, Siemens AG, Mediso Ltd., Laserglow Technologies, Mightex Systems, Prizmatix, Noldus Information Technology, NeuroNexus, Scientifica, Femtonics Ltd. and among others.
From both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neuroscience market in these regions.
The neuroscience market is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising government spending on healthcare infrastructure in developed regions, increasing geriatric population and rising technological advancements. However, the neuroscience-based initiatives by government bodies is anticipated to offer more growth opportunities for the players operating in the neuroscience market.
Read More About Industry Changes@ http://bit.ly/2S47hj3
Including both qualitative and quantitative information. It provides overview and forecast of the global neuroscience market based on component, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuroscience market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Neuroscience market is segmented on the basis of component and end user. Based on component, the neuroscience market is segmented as, instrument, software and services. The instrument segment is further bifurcated into MRI imaging systems and neuro-microscopy. On the basis of end user, the neuroscience market is categorized as, hospitals, diagnostics laboratories, research institutes and academic institutes.